Advertisement
Daxor Corporation

Daxor Corporation (DXR) Stock Overview

Explore Daxor Corporation’s financial performance, market position, analyst ratings, and future outlook.

DXRNASDAQ
HealthcareMedical - Instruments & Supplies
$9.26
$0.84(8.32%)
U.S. Market is Open · 13:27
Advertisement

Daxor Corporation (DXR)

Meyka AI Score

Z

Key Financials

Market Cap50.4M
P/E Ratio5.39
EPS (TTM)$1.64
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

DXR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Daxor Corporation (DXR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of F, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 42.07, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of N/A.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 5.39 and a market capitalization of 50.4M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.40%
5-Day Change
-7.92%
1-Month Change
-1.91%
3-Month Change
-14.98%
6-Month Change
-21.92%
Year-to-Date (YTD) Change
-33.83%
1-Year Change
5.06%
3-Year Change
2.20%
5-Year Change
-26.67%
All-Time (Max) Change
2.74%

Contact Information

12123308500
109 Meco Lane, Oak Ridge, TN, 37830

Company Facts

37 Employees
IPO DateJul 25, 1983
CountryUS
Actively Trading

Frequently Asked Questions